Biolinq snags $58M for ‘smallest biosensor in the world’

The latest stories trending on MedCity News.

Editor's Pick

Top Story Biolinq Snags $58M for 'Smallest Biosensor in the World' Biolinq raked in $58 million in capital this week. The company is developing a wearable patch that uses electrochemical sensors to measure a person's glucose levels from the intradermal space just beneath the surface of their skin.

Featured News

Startup Launches Out of Redesign Health To Help Employees Build Their Own Benefits Beanstalk Benefits vets benefits solutions and aggregates them into a single platform. Employees can build their own benefits portfolio using the platform. J&J-Partnered Contineum Corrals $110M From IPO for Clinical Trials in Fibrosis & MS Contineum Therapeutics plans to spend most of its IPO cash on clinical testing of a lead drug candidate in development for idiopathic pulmonary fibrosis and multiple sclerosis. This small molecule blocks a competitive target pursued by several other companies, including Bristol Myers Squibb and AbbVie. Orchestrating Care in the New World of Distributive Access The challenge with the emerging model of "distributive access" is that there isn't any one individual or entity coordinating everything; patients are left to navigate their own care journeys. And while health systems invested billions of dollars in technology, little of it is well-coordinated or well-orchestrated for the health system, for healthcare workers, or for patients. Smarter Aging: The Importance of Health Tech Planning In today's tech-savvy world, weaving Health Tech Planning into the fabric of care for older adults is essential.

Resources

A Conversation About Wearable Robots with Scott Davis In this final episode of Season 1, which focuses on the world of medtech, Scott Davis, CEO of Ekso Bionics, delves into the history of the company and the novel devices that Ekso has built. Listen Now

MedCity News • PO Box 901 • New York, NY unsubscribe